---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-179391"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-04-27T23:59:59+00:00"
generated_at: "2026-05-15T03:51:11.070332+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health granted Nasdaq extension to May 15, 2026; announces 1-for-35 reverse stock split

## Summary
- Nasdaq Panel grants extension until May 15, 2026 to demonstrate compliance with $1.00 minimum bid price rule.
- Company must close at $1.00+ for at least 10 consecutive business days by May 15.
- Reverse stock split at 1-for-35 effective April 30, 2026; trading continues on Nasdaq under JAGX.
- Reverse split approved at April 20, 2026 special meeting; no fractional shares – cash in lieu.
- Panel retains jurisdiction until September 1, 2026; delisting risk persists if compliance not met.

## SEC filing metadata
- accession: 0001193125-26-179391
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-04-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526179391/0001193125-26-179391-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526179391/d109088d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-179391
- JSON: https://secwatch.observer/filing/0001193125-26-179391.json
- Plain text: https://secwatch.observer/filing/0001193125-26-179391.txt

## Source-grounded claims
- claim_id: 29febf435701ff486c2894191b8f7bc8b79bc5f3
  claim: Jaguar Health, Inc. received a nasdaq hearing update notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv), 5810(c)(3)(A)).
  evidence_excerpt: April 24, 2026, Jaguar Health, Inc. (the “Company”) received a decision letter from the Nasdaq Hearings Panel (“Panel”) granting the Company’s request to continue its listing on The Nasdaq Stock Market LLC (“Nasdaq”), su
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526179391/0001193125-26-179391-index.htm
- claim_id: 1ed3755fda914724c8141d8f2429c576e283cbc6
  claim: Jaguar Health, Inc.: Filed Eleventh Amendment to Third Amended and Restated Certificate of Incorporation to effect a 1-for-35 reverse stock split (effective 2026-04-30).
  evidence_excerpt: the Company filed the Eleventh Amendment with the Secretary of State of the State of Delaware. The Reverse Stock Split will become effective in accordance with the terms of the Eleventh Amendment at 12:01 am Eastern Time on April 30, 2026
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526179391/0001193125-26-179391-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.